These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of atrial natriuretic peptide versus mannitol on renal blood flow during radiocontrast infusion in chronic renal failure. Kurnik BR, Weisberg LS, Cuttler IM, Kurnik PB. J Lab Clin Med; 1990 Jul; 116(1):27-36. PubMed ID: 2142949 [Abstract] [Full Text] [Related]
3. Dopamine and renal blood flow in radiocontrast-induced nephropathy in humans. Weisberg LS, Kurnik PB, Kurnik BR. Ren Fail; 1993 Jul; 15(1):61-8. PubMed ID: 8441838 [Abstract] [Full Text] [Related]
4. Induction and prevention of radiocontrast-induced nephropathy in dogs with heart failure. Margulies KB, McKinley LJ, Cavero PG, Burnett JC. Kidney Int; 1990 Dec; 38(6):1101-8. PubMed ID: 2150085 [Abstract] [Full Text] [Related]
5. Cystatin C and creatinine as markers for radiocontrast-induced nephropathy in patients treated with N-acetylcysteine. Merkle M, Sauter M, Argirov M, Wörnle M. Ren Fail; 2010 Jan; 32(1):85-90. PubMed ID: 20113272 [Abstract] [Full Text] [Related]
7. Prevention of contrast media-induced renal dysfunction with prostaglandin E1: a randomized, double-blind, placebo-controlled study. Sketch MH, Whelton A, Schollmayer E, Koch JA, Bernink PJ, Woltering F, Brinker J, Prostaglandin E1 Study Group. Am J Ther; 2001 Jan; 8(3):155-62. PubMed ID: 11344383 [Abstract] [Full Text] [Related]
8. Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy. Allaqaband S, Tumuluri R, Malik AM, Gupta A, Volkert P, Shalev Y, Bajwa TK. Catheter Cardiovasc Interv; 2002 Nov; 57(3):279-83. PubMed ID: 12410497 [Abstract] [Full Text] [Related]
9. Incidence and risk factors for radiocontrast-induced nephropathy in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization. Cho HS, Seo JW, Kang Y, Bae EJ, Kim HJ, Chang SH, Park DJ. Clin Exp Nephrol; 2011 Oct; 15(5):714-719. PubMed ID: 21695415 [Abstract] [Full Text] [Related]
10. Fenoldopam mesylate blocks reductions in renal plasma flow after radiocontrast dye infusion: a pilot trial in the prevention of contrast nephropathy. Tumlin JA, Wang A, Murray PT, Mathur VS. Am Heart J; 2002 May; 143(5):894-903. PubMed ID: 12040355 [Abstract] [Full Text] [Related]
11. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Bartholomew BA, Harjai KJ, Dukkipati S, Boura JA, Yerkey MW, Glazier S, Grines CL, O'Neill WW. Am J Cardiol; 2004 Jun 15; 93(12):1515-9. PubMed ID: 15194023 [Abstract] [Full Text] [Related]